- Rockwell Automation Earnings: What Options Are Saying
- Gold Will Touch Higher Lows and Higher Highs: Analyst
- Correction Coming When Fed Ends 'Easy Money': Market Pro
- Risk Is More 'Enticing' Now: Chief Economist
- Olin Options Indicate a Rebound
- S&P to Finish Above 1,100 by Year-End: Market Analyst
- Smartphone Landscape to Change Dramatically in Asia
- This Bear-Market Rally Has 'Turned': Elliot Wave's Hochberg
- Expect 33% Earnings Increase in 2010: S&P’s Sam Stovall
- Art Cashin: Fed 'Doesn't Believe' the Recovery Yet
- Tamminen: Why Does Oklahoma Want To Drown New York?
- Food Network, HGTV Drive Scripps Networks' Upside Surprise
- Tommy Lee, Medical Tourism and Nasty Santa, Your Emails
- U.S. Markets Gain 3% for the Week Despite 10.2% Unemployment
- Disney's 'Carol' Tests Widest 3-D Release Ever
- Stimulus II? Jobs Tax Credit=Cash For Clunkers
- Rockwell Automation Earnings: What Options Are Saying
- Gold Will Touch Higher Lows and Higher Highs: Analyst
- Is Misery Alive And Well in Your Office?
- BoA Board in Civil War Over Lewis' Succesor
- For the Jobless, 10% is Harder Than Before
- Week Ahead: Stocks Search for Catalyst in Quiet Week
- Outlook: Dollar to Ride Higher on Bleak Jobs Report
- Geithner: More Stimulus, Not a Bank Tax
- Windfall is Seen as Bank Bonuses are Paid in Stock
- Volatility Returns: Sign of the Bull Losing Muscle?
- Cramer: Earnings, IPOs Dominate Next Week
- Buying Fear: How to Own Volatility
RSS FEED
CNBC Stock Blog
Text Size 
Gabe Hilmoe is getting an early start on the stock market. He's portfolio manager of the Henry Fund at the University of Iowa, and he's got some strong ideas about equity investments.
The Henry Fund, like many student-run investment vehicles, operates with real money, and the 12 MBA students who run it currently handle about $1.5 million. Hilmoe specializes in the health-care side of the portfolio.
Recommendations:
"Right now, we still like Genentech [DNA
Loading...
()
]," he told CNBC. "We still see more upside, with another Roche bid coming in."
It's not just biotech that he likes; in the medical device field, he's enthusiastic about Stryker [SYK
Loading...
()
].
"It's definitely a growth story," he said. "We see a huge upside in terms of a demographic trend: A lot more people are getting orthopedic surgery, and it's becoming more popular with a younger population as well."
Hilmoe has a pick outside health care as well: Sherwin Williams [SHW
Loading...
()
], a seemingly contrarian play because its best-known product, paint, is so closely tied to housing.
"The idea is that less than 10 percent of their revenues are tied to new residential construction," he explained. "We see a lot of opportunity in emerging markets and...it has room to grow."
________________________
NEW!
________________________
Disclosures:
Disclosure information for Gabe Hilmoe was not immediately available.
Data is a real-time snapshot *Data is delayed at least 15 minutes